Sinsin Pharmaceutical Co. Ltd (002800) — Capital Reinvestment Ratio
Sinsin Pharmaceutical Co. Ltd (002800) has a Capital Reinvestment Ratio of 0.19x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩4.70 Billion) in capital expenditures (₩871.54 Million). Check tangible equity quality of Sinsin Pharmaceutical Co. Ltd to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Sinsin Pharmaceutical Co. Ltd Capital Reinvestment Ratio (2015–2024)
This chart tracks Sinsin Pharmaceutical Co. Ltd's Capital Reinvestment Ratio across 9 annual periods. For the full cash flow conversion analysis, see Sinsin Pharmaceutical Co. Ltd cash conversion from operations.
Annual Capital Reinvestment Ratio for Sinsin Pharmaceutical Co. Ltd (2015–2024)
Year-by-year Capital Reinvestment Ratio for Sinsin Pharmaceutical Co. Ltd from 2015 to 2024. See Sinsin Pharmaceutical Co. Ltd free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.25x | ₩5.94 Billion | ₩1.51 Billion | ▼ -80.1% |
| 2023 | 1.28x | ₩3.93 Billion | ₩5.03 Billion | ▲ +670.0% |
| 2022 | 0.17x | ₩5.46 Billion | ₩907.13 Million | ▼ -99.9% |
| 2021 | 115.70x | ₩23.18 Million | ₩2.68 Billion | ▲ +1702.9% |
| 2020 | 6.42x | ₩1.87 Billion | ₩11.97 Billion | ▼ -80.5% |
| 2018 | 32.86x | ₩774.24 Million | ₩25.44 Billion | ▲ +4103.1% |
| 2017 | 0.78x | ₩4.57 Billion | ₩3.57 Billion | ▼ -70.6% |
| 2016 | 2.66x | ₩2.79 Billion | ₩7.43 Billion | ▲ +166.7% |
| 2015 | 1.00x | ₩5.24 Billion | ₩5.22 Billion | — |